0 |
TUBERCULIN TEST FALSE POSITIVE |
103 |
0.7803 |
1 |
ELECTROMYOGRAM NORMAL |
1 |
0.5000 |
2 |
TUBERCULIN TEST NEGATIVE |
3 |
0.3333 |
3 |
VACCINATION SITE NECROSIS |
1 |
0.3333 |
4 |
FALSE POSITIVE TUBERCULOSIS TEST |
96 |
0.3232 |
5 |
VACCINATION SITE INDURATION |
6 |
0.2400 |
6 |
BLOOD CADMIUM INCREASED |
1 |
0.2000 |
7 |
VACCINATION SITE IRRITATION |
1 |
0.2000 |
8 |
VACCINATION SITE INFLAMMATION |
8 |
0.1818 |
9 |
VACCINATION SITE PRURITUS |
7 |
0.1667 |
10 |
VACCINATION SITE RASH |
5 |
0.1613 |
11 |
NO ADVERSE DRUG REACTION |
10 |
0.1429 |
12 |
EXTENSIVE SWELLING OF VACCINATED LIMB |
3 |
0.1429 |
13 |
VACCINATION SITE CELLULITIS |
2 |
0.1429 |
14 |
VACCINATION SITE VESICLES |
2 |
0.1250 |
15 |
TUBERCULOSIS SKIN TEST POSITIVE |
9 |
0.1111 |
16 |
GASTROENTERITIS NORWALK VIRUS |
2 |
0.1053 |
17 |
COW POX |
1 |
0.1000 |
18 |
VACCINATION SITE LYMPHADENOPATHY |
1 |
0.1000 |
19 |
VACCINATION SITE ERYTHEMA |
10 |
0.0654 |
20 |
MANUFACTURING PRODUCT STORAGE ISSUE |
4 |
0.0556 |
21 |
BLADDER NECK OPERATION |
1 |
0.0500 |
22 |
VACCINATION SITE BRUISING |
1 |
0.0435 |
23 |
POOR QUALITY PRODUCT ADMINISTERED |
239 |
0.0435 |
24 |
OVARIAN INFECTION |
1 |
0.0417 |
25 |
VACCINATION SITE REACTION |
3 |
0.0370 |
26 |
POLYMORPHIC ERUPTION OF PREGNANCY |
1 |
0.0357 |
27 |
OILY SKIN |
1 |
0.0256 |
28 |
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST |
1 |
0.0256 |
29 |
INTRANASAL PARAESTHESIA |
1 |
0.0250 |
30 |
EXPOSURE VIA EYE CONTACT |
6 |
0.0221 |
31 |
DIALYSIS HYPOTENSION |
1 |
0.0217 |
32 |
HISTAMINE ABNORMAL |
1 |
0.0213 |
33 |
URTICARIA LOCALISED |
1 |
0.0213 |
34 |
FACTOR VII DEFICIENCY |
1 |
0.0192 |
35 |
ERYTHEMA INDURATUM |
2 |
0.0180 |
36 |
RENAL SCAN ABNORMAL |
1 |
0.0172 |
37 |
LYMPHOCYTE COUNT |
1 |
0.0169 |
38 |
WRONG PRODUCT ADMINISTERED |
70 |
0.0159 |
39 |
PENILE ABSCESS |
1 |
0.0159 |
40 |
PEPTOSTREPTOCOCCUS INFECTION |
1 |
0.0128 |
41 |
KOEBNER PHENOMENON |
1 |
0.0128 |
42 |
INDURATION |
18 |
0.0120 |
43 |
VISUAL FIELD TESTS ABNORMAL |
1 |
0.0115 |
44 |
LOCAL REACTION |
7 |
0.0114 |
45 |
PARAESTHESIA MUCOSAL |
1 |
0.0114 |
46 |
TRACHEAL INFLAMMATION |
1 |
0.0109 |
47 |
AGONAL RESPIRATION |
1 |
0.0109 |
48 |
TUBERCULIN TEST POSITIVE |
26 |
0.0108 |
49 |
PITUITARY CYST |
1 |
0.0105 |
50 |
INJECTION SITE STREAKING |
2 |
0.0103 |
51 |
INJECTION SITE INDURATION |
114 |
0.0102 |
52 |
SYNCOPE VASOVAGAL |
8 |
0.0096 |
53 |
BASAL GANGLIA STROKE |
1 |
0.0096 |
54 |
RASH SCALY |
1 |
0.0095 |
55 |
CELLULITIS OF MALE EXTERNAL GENITAL ORGAN |
1 |
0.0094 |
56 |
INJECTION SITE OEDEMA |
13 |
0.0094 |
57 |
INJECTED LIMB MOBILITY DECREASED |
1 |
0.0093 |
58 |
UNRESPONSIVE TO VERBAL STIMULI |
2 |
0.0093 |
59 |
REGURGITATION OF FOOD |
1 |
0.0093 |
60 |
VACCINATION SITE PAIN |
4 |
0.0092 |
61 |
INJECTION SITE VESICLES |
39 |
0.0091 |
62 |
ALLERGY TO VACCINE |
2 |
0.0086 |
63 |
INJECTION SITE DERMATITIS |
1 |
0.0085 |
64 |
ARTERIOVENOUS FISTULA SITE INFECTION |
1 |
0.0081 |
65 |
INCISION SITE OEDEMA |
1 |
0.0079 |
66 |
PARAKERATOSIS |
2 |
0.0077 |
67 |
ACANTHOSIS |
2 |
0.0075 |
68 |
INJECTION SITE CELLULITIS |
11 |
0.0073 |
69 |
BRACHIAL PLEXUS INJURY |
1 |
0.0070 |
70 |
WRONG DRUG ADMINISTERED |
61 |
0.0068 |
71 |
ARTERIOVENOUS FISTULA OCCLUSION |
1 |
0.0064 |
72 |
PRURITUS ALLERGIC |
6 |
0.0063 |
73 |
URTICARIA GENERALISED |
4 |
0.0062 |
74 |
PRODUCT STORAGE ERROR |
291 |
0.0061 |
75 |
APPLICATION SITE HAEMATOMA |
1 |
0.0058 |
76 |
BRACHIAL PLEXOPATHY |
1 |
0.0057 |
77 |
EYE ROLLING |
4 |
0.0057 |
78 |
SHOULDER DEFORMITY |
1 |
0.0056 |
79 |
HEPATITIS A ANTIBODY POSITIVE |
1 |
0.0055 |
80 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
10 |
0.0053 |
81 |
TESTICULAR MASS |
1 |
0.0053 |
82 |
FAECAL OCCULT BLOOD POSITIVE |
1 |
0.0052 |
83 |
INJECTION SITE NERVE DAMAGE |
1 |
0.0052 |
84 |
SKIN INFLAMMATION |
1 |
0.0051 |
85 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
56 |
0.0051 |
86 |
VOCAL CORD PARESIS |
1 |
0.0051 |
87 |
CORNEAL THINNING |
1 |
0.0049 |
88 |
INJECTION SITE INFLAMMATION |
18 |
0.0047 |
89 |
EXPIRED PRODUCT ADMINISTERED |
123 |
0.0046 |
90 |
LACUNAR STROKE |
1 |
0.0045 |
91 |
ERYTHEMA INFECTIOSUM |
1 |
0.0044 |
92 |
BLOOD CREATINE DECREASED |
1 |
0.0043 |
93 |
ANION GAP DECREASED |
1 |
0.0042 |
94 |
INJECTION SITE CYST |
1 |
0.0042 |
95 |
LATEX ALLERGY |
1 |
0.0041 |
96 |
GLOBULINS DECREASED |
1 |
0.0040 |
97 |
LYMPH NODE PAIN |
6 |
0.0039 |
98 |
ADMINISTRATION SITE SWELLING |
1 |
0.0039 |
99 |
CORNEAL INFILTRATES |
1 |
0.0039 |
100 |
TONIC CLONIC MOVEMENTS |
4 |
0.0039 |
101 |
SCARLET FEVER |
1 |
0.0039 |
102 |
CAT SCRATCH DISEASE |
1 |
0.0039 |
103 |
LOSS OF PROPRIOCEPTION |
1 |
0.0038 |
104 |
SKIN TEST POSITIVE |
3 |
0.0037 |
105 |
SUSPECTED PRODUCT QUALITY ISSUE |
4 |
0.0037 |
106 |
SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG |
1 |
0.0036 |
107 |
BASAL GANGLIA INFARCTION |
1 |
0.0035 |
108 |
INJECTION SITE PUSTULE |
1 |
0.0035 |
109 |
RENAL HYPERTENSION |
1 |
0.0035 |
110 |
PROTEUS INFECTION |
2 |
0.0035 |
111 |
SKIN BACTERIAL INFECTION |
2 |
0.0035 |
112 |
SUBCUTANEOUS NODULE |
1 |
0.0035 |
113 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG |
1 |
0.0034 |
114 |
SCROTAL ABSCESS |
1 |
0.0034 |
115 |
BURNING SENSATION MUCOSAL |
1 |
0.0034 |
116 |
INJECTION SITE WARMTH |
60 |
0.0033 |
117 |
LYMPHOID TISSUE HYPERPLASIA |
1 |
0.0033 |
118 |
GAIT SPASTIC |
1 |
0.0032 |
119 |
BRAIN CONTUSION |
2 |
0.0031 |
120 |
BODY MASS INDEX INCREASED |
3 |
0.0030 |
121 |
SKIN WARM |
14 |
0.0030 |
122 |
TONIC CONVULSION |
3 |
0.0029 |
123 |
INJECTION SITE NECROSIS |
5 |
0.0028 |
124 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
1 |
0.0027 |
125 |
SEXUALLY INAPPROPRIATE BEHAVIOUR |
1 |
0.0027 |
126 |
LACK OF SPONTANEOUS SPEECH |
1 |
0.0026 |
127 |
LYMPHADENITIS |
5 |
0.0026 |
128 |
POOR QUALITY DRUG ADMINISTERED |
17 |
0.0026 |
129 |
INJECTION SITE IRRITATION |
27 |
0.0026 |
130 |
INJECTION SITE BURNING |
2 |
0.0026 |
131 |
ARTERIOVENOUS MALFORMATION |
2 |
0.0025 |
132 |
AXILLARY PAIN |
3 |
0.0025 |
133 |
TYPE III IMMUNE COMPLEX MEDIATED REACTION |
1 |
0.0025 |
134 |
ASPARTATE AMINOTRANSFERASE DECREASED |
1 |
0.0024 |
135 |
INJECTION SITE RASH |
55 |
0.0024 |
136 |
ACCIDENTAL EXPOSURE |
10 |
0.0024 |
137 |
INJECTION SITE ERYTHEMA |
239 |
0.0024 |
138 |
TRACHEAL DISORDER |
1 |
0.0024 |
139 |
SKIN OEDEMA |
2 |
0.0024 |
140 |
KELOID SCAR |
1 |
0.0023 |
141 |
CORNEAL EPITHELIUM DEFECT |
1 |
0.0022 |
142 |
INJECTION SITE PRURITUS |
119 |
0.0022 |
143 |
DRUG ADMINISTRATION ERROR |
67 |
0.0022 |
144 |
PRE-EXISTING DISEASE |
1 |
0.0021 |
145 |
POSTURING |
1 |
0.0021 |
146 |
CHEST X-RAY ABNORMAL |
6 |
0.0021 |
147 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
76 |
0.0021 |
148 |
STATUS ASTHMATICUS |
1 |
0.0021 |
149 |
FOOD REFUSAL |
1 |
0.0021 |
150 |
SENSATION OF HEAVINESS |
8 |
0.0021 |
151 |
MARKEDLY REDUCED DIETARY INTAKE |
1 |
0.0020 |
152 |
PULSE PRESSURE DECREASED |
1 |
0.0020 |
153 |
NO REACTION ON PREVIOUS EXPOSURE TO DRUG |
1 |
0.0020 |
154 |
HYPOAESTHESIA FACIAL |
3 |
0.0020 |
155 |
PERNICIOUS ANAEMIA |
1 |
0.0019 |
156 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0019 |
157 |
DELIVERY |
1 |
0.0019 |
158 |
GUILLAIN-BARRE SYNDROME |
7 |
0.0019 |
159 |
CERVICOBRACHIAL SYNDROME |
1 |
0.0018 |
160 |
INJECTION SITE DISCOLOURATION |
18 |
0.0018 |
161 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0018 |
162 |
ANTERIOR CHAMBER CELL |
1 |
0.0018 |
163 |
SOFT TISSUE NECROSIS |
1 |
0.0018 |
164 |
ARTERIOVENOUS FISTULA SITE COMPLICATION |
1 |
0.0018 |
165 |
REFLEXES ABNORMAL |
1 |
0.0017 |
166 |
CROUP INFECTIOUS |
1 |
0.0017 |
167 |
TONGUE PRURITUS |
1 |
0.0017 |
168 |
ALLODYNIA |
1 |
0.0017 |
169 |
ORAL PRURITUS |
3 |
0.0017 |
170 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
8 |
0.0016 |
171 |
TONGUE PARALYSIS |
1 |
0.0016 |
172 |
VITAL FUNCTIONS ABNORMAL |
1 |
0.0016 |
173 |
PNEUMONIA CRYPTOCOCCAL |
1 |
0.0016 |
174 |
LYMPH NODE TUBERCULOSIS |
1 |
0.0016 |
175 |
ESCHAR |
1 |
0.0015 |
176 |
LOCALISED OEDEMA |
6 |
0.0015 |
177 |
REACTION TO PRESERVATIVES |
1 |
0.0015 |
178 |
INJECTION SITE URTICARIA |
27 |
0.0015 |
179 |
INJECTION SITE ABSCESS |
3 |
0.0015 |
180 |
ANAPHYLACTOID REACTION |
5 |
0.0015 |
181 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0014 |
182 |
LABORATORY TEST INTERFERENCE |
1 |
0.0014 |
183 |
STARING |
3 |
0.0014 |
184 |
AORTIC DISORDER |
1 |
0.0014 |
185 |
EXCESSIVE GRANULATION TISSUE |
1 |
0.0014 |
186 |
THROAT TIGHTNESS |
31 |
0.0014 |
187 |
BLADDER CATHETERISATION |
1 |
0.0014 |
188 |
NEPHROGENIC ANAEMIA |
6 |
0.0014 |
189 |
LUNG HYPERINFLATION |
1 |
0.0014 |
190 |
FOOD INTERACTION |
2 |
0.0013 |
191 |
DEAFNESS TRANSITORY |
1 |
0.0013 |
192 |
PERTUSSIS |
1 |
0.0013 |
193 |
ADMINISTRATION SITE PAIN |
1 |
0.0013 |
194 |
INJECTION SITE SCAB |
1 |
0.0013 |
195 |
SPUTUM CULTURE POSITIVE |
1 |
0.0013 |
196 |
SERUM SICKNESS |
3 |
0.0013 |
197 |
COLOUR BLINDNESS |
1 |
0.0013 |
198 |
CULTURE POSITIVE |
1 |
0.0013 |
199 |
STRIDOR |
3 |
0.0012 |
200 |
BREAST ABSCESS |
1 |
0.0012 |
201 |
PARAESTHESIA ORAL |
14 |
0.0012 |
202 |
EAR HAEMORRHAGE |
2 |
0.0012 |
203 |
PRURIGO |
1 |
0.0012 |
204 |
LYMPHOCYTIC INFILTRATION |
1 |
0.0012 |
205 |
CARPAL TUNNEL DECOMPRESSION |
1 |
0.0012 |
206 |
LIVEDO RETICULARIS |
2 |
0.0012 |
207 |
FALSE POSITIVE INVESTIGATION RESULT |
1 |
0.0012 |
208 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0011 |
209 |
NEUROMYOPATHY |
1 |
0.0011 |
210 |
LYME DISEASE |
3 |
0.0011 |
211 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0011 |
212 |
GROIN ABSCESS |
1 |
0.0011 |
213 |
NAIL GROWTH ABNORMAL |
1 |
0.0011 |
214 |
EXPOSURE VIA SKIN CONTACT |
3 |
0.0011 |
215 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
4 |
0.0011 |
216 |
INJECTION SITE SWELLING |
62 |
0.0011 |
217 |
PHARYNGEAL OEDEMA |
16 |
0.0011 |
218 |
IMMEDIATE POST-INJECTION REACTION |
1 |
0.0010 |
219 |
SHOULDER PAIN |
1 |
0.0010 |
220 |
INJECTION SITE REACTION |
57 |
0.0010 |
221 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0010 |
222 |
PALLOR |
23 |
0.0010 |
223 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0010 |
224 |
THROMBOPHLEBITIS SUPERFICIAL |
3 |
0.0010 |
225 |
ALVEOLITIS ALLERGIC |
1 |
0.0010 |
226 |
MULTIMORBIDITY |
1 |
0.0010 |
227 |
INJECTION SITE PARAESTHESIA |
1 |
0.0010 |
228 |
CARBON DIOXIDE INCREASED |
1 |
0.0009 |
229 |
BLOOD UREA DECREASED |
1 |
0.0009 |
230 |
NO ADVERSE EVENT |
112 |
0.0009 |
231 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
1 |
0.0009 |
232 |
PRESYNCOPE |
18 |
0.0009 |
233 |
REACTION TO DRUG EXCIPIENTS |
2 |
0.0009 |
234 |
VACCINATION FAILURE |
1 |
0.0009 |
235 |
INJECTION SITE SCAR |
2 |
0.0009 |
236 |
PRODUCT QUALITY ISSUE |
109 |
0.0009 |
237 |
OPEN WOUND |
1 |
0.0009 |
238 |
APPLICATION SITE WARMTH |
1 |
0.0009 |
239 |
AREFLEXIA |
2 |
0.0009 |
240 |
LARYNGOSPASM |
2 |
0.0009 |
241 |
RASH ERYTHEMATOUS |
29 |
0.0009 |
242 |
HYPERPARATHYROIDISM SECONDARY |
2 |
0.0009 |
243 |
TENOSYNOVITIS |
2 |
0.0008 |
244 |
EAR PRURITUS |
2 |
0.0008 |
245 |
SEIZURE LIKE PHENOMENA |
1 |
0.0008 |
246 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0008 |
247 |
TENDERNESS |
7 |
0.0008 |
248 |
INJECTION SITE PAPULE |
3 |
0.0008 |
249 |
MENINGITIS CRYPTOCOCCAL |
1 |
0.0008 |
250 |
PRURITUS GENERALISED |
17 |
0.0008 |
251 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
9 |
0.0008 |
252 |
PAPILLOMA VIRAL INFECTION |
1 |
0.0008 |
253 |
PULMONARY FUNCTION TEST ABNORMAL |
1 |
0.0008 |
254 |
COMPLEX REGIONAL PAIN SYNDROME |
1 |
0.0008 |
255 |
ANGIONEUROTIC OEDEMA |
2 |
0.0007 |
256 |
ANAPHYLACTIC REACTION |
31 |
0.0007 |
257 |
HYPOPNOEA |
2 |
0.0007 |
258 |
SKULL FRACTURE |
1 |
0.0007 |
259 |
PUSTULAR PSORIASIS |
2 |
0.0007 |
260 |
NONSPECIFIC REACTION |
3 |
0.0007 |
261 |
GRANULOMA |
2 |
0.0007 |
262 |
VENA CAVA THROMBOSIS |
1 |
0.0007 |
263 |
ERYTHEMA |
118 |
0.0007 |
264 |
CHOREA |
1 |
0.0007 |
265 |
POLYCYTHAEMIA |
1 |
0.0007 |
266 |
INTERMITTENT CLAUDICATION |
1 |
0.0007 |
267 |
PHARMACEUTICAL PRODUCT COMPLAINT |
18 |
0.0007 |
268 |
SPINAL DEFORMITY |
1 |
0.0007 |
269 |
SACROILIITIS |
1 |
0.0007 |
270 |
INJECTION SITE DISCHARGE |
1 |
0.0007 |
271 |
INTERCEPTED DRUG DISPENSING ERROR |
1 |
0.0007 |
272 |
PHLEBITIS |
3 |
0.0007 |
273 |
VOCAL CORD PARALYSIS |
1 |
0.0007 |
274 |
DERMATITIS PSORIASIFORM |
1 |
0.0007 |
275 |
DYSENTERY |
1 |
0.0007 |
276 |
SKIN LESION |
14 |
0.0007 |
277 |
SWOLLEN TONGUE |
17 |
0.0006 |
278 |
NASAL SEPTUM DEVIATION |
1 |
0.0006 |
279 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0006 |
280 |
WOUND INFECTION STAPHYLOCOCCAL |
1 |
0.0006 |
281 |
LATENT TUBERCULOSIS |
1 |
0.0006 |
282 |
OESOPHAGEAL SPASM |
1 |
0.0006 |
283 |
RASH GENERALISED |
16 |
0.0006 |
284 |
WHEEZING |
27 |
0.0006 |
285 |
CONVERSION DISORDER |
1 |
0.0006 |
286 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0006 |
287 |
RASH PUSTULAR |
4 |
0.0006 |
288 |
BILIARY DYSKINESIA |
1 |
0.0006 |
289 |
SELF-MEDICATION |
2 |
0.0006 |
290 |
RESPIRATION ABNORMAL |
3 |
0.0006 |
291 |
RASH PAPULAR |
11 |
0.0006 |
292 |
BLISTER |
25 |
0.0006 |
293 |
MICROCYTIC ANAEMIA |
1 |
0.0006 |
294 |
TUBERCULOSIS |
6 |
0.0006 |
295 |
PHARYNGOLARYNGEAL PAIN |
3 |
0.0006 |
296 |
MUSCLE CRAMP |
1 |
0.0006 |
297 |
CORNEAL DISORDER |
1 |
0.0006 |
298 |
DROOLING |
3 |
0.0006 |
299 |
NEUROGENIC BLADDER |
1 |
0.0006 |
300 |
ATRIAL THROMBOSIS |
1 |
0.0006 |
301 |
INTERCEPTED PRODUCT STORAGE ERROR |
1 |
0.0006 |
302 |
HYPERSENSITIVITY |
83 |
0.0006 |
303 |
FLAT AFFECT |
1 |
0.0005 |
304 |
PURULENT DISCHARGE |
2 |
0.0005 |
305 |
MONOPLEGIA |
2 |
0.0005 |
306 |
PERIARTHRITIS |
1 |
0.0005 |
307 |
GRAND MAL CONVULSION |
5 |
0.0005 |
308 |
URTICARIA |
70 |
0.0005 |
309 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0005 |
310 |
EYELID DISORDER |
1 |
0.0005 |
311 |
DERMATOMYOSITIS |
1 |
0.0005 |
312 |
LYMPHADENOPATHY |
15 |
0.0005 |
313 |
EMERGENCY CARE |
1 |
0.0005 |
314 |
PRE-ECLAMPSIA |
2 |
0.0005 |
315 |
PARESIS |
1 |
0.0005 |
316 |
PULSE ABNORMAL |
1 |
0.0005 |
317 |
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE |
1 |
0.0005 |
318 |
VARICELLA |
1 |
0.0005 |
319 |
ELECTROCARDIOGRAM T WAVE INVERSION |
1 |
0.0005 |
320 |
ACUTE PSYCHOSIS |
1 |
0.0005 |
321 |
NEAR DEATH EXPERIENCE |
1 |
0.0005 |
322 |
DILATATION VENTRICULAR |
1 |
0.0005 |
323 |
PROCTITIS |
1 |
0.0005 |
324 |
UNRESPONSIVE TO STIMULI |
10 |
0.0005 |
325 |
APPLICATION SITE URTICARIA |
1 |
0.0005 |
326 |
RASH PRURITIC |
20 |
0.0005 |
327 |
INCORRECT DOSE ADMINISTERED |
72 |
0.0005 |
328 |
IMPAIRED SELF-CARE |
1 |
0.0005 |
329 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0005 |
330 |
VASODILATATION |
1 |
0.0005 |
331 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
332 |
ABDOMINAL RIGIDITY |
1 |
0.0005 |
333 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0005 |
334 |
FACIAL PALSY |
1 |
0.0005 |
335 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0005 |
336 |
LOCAL SWELLING |
8 |
0.0005 |
337 |
SENSATION OF FOREIGN BODY |
3 |
0.0005 |
338 |
CYANOSIS |
6 |
0.0005 |
339 |
SKIN FRAGILITY |
1 |
0.0004 |
340 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
2 |
0.0004 |
341 |
DEAFNESS UNILATERAL |
2 |
0.0004 |
342 |
URINE OUTPUT INCREASED |
1 |
0.0004 |
343 |
PRODUCT CONTAMINATION |
1 |
0.0004 |
344 |
SKIN REACTION |
5 |
0.0004 |
345 |
RASH MACULAR |
12 |
0.0004 |
346 |
CLONUS |
1 |
0.0004 |
347 |
NECK MASS |
1 |
0.0004 |
348 |
NYSTAGMUS |
2 |
0.0004 |
349 |
EOSINOPHILIC PNEUMONIA |
1 |
0.0004 |
350 |
CELLULITIS |
18 |
0.0004 |
351 |
PRURITUS |
116 |
0.0004 |
352 |
MASS |
5 |
0.0004 |
353 |
SENSORY DISTURBANCE |
6 |
0.0004 |
354 |
SYNCOPE |
35 |
0.0004 |
355 |
HYPERAESTHESIA |
3 |
0.0004 |
356 |
RESPIRATORY RATE INCREASED |
3 |
0.0004 |
357 |
JOINT LOCK |
1 |
0.0004 |
358 |
EMBOLISM VENOUS |
1 |
0.0004 |
359 |
ESCHERICHIA SEPSIS |
1 |
0.0004 |
360 |
TYPE I HYPERSENSITIVITY |
1 |
0.0004 |
361 |
MYELOFIBROSIS |
1 |
0.0004 |
362 |
MUSCLE RIGIDITY |
4 |
0.0004 |
363 |
DYSAESTHESIA |
1 |
0.0004 |
364 |
PYODERMA GANGRENOSUM |
1 |
0.0004 |
365 |
COLD SWEAT |
6 |
0.0004 |
366 |
INJECTION SITE PAIN |
91 |
0.0004 |
367 |
CUSHINGOID |
1 |
0.0004 |
368 |
EXPIRED DRUG ADMINISTERED |
2 |
0.0004 |
369 |
LIP SWELLING |
11 |
0.0004 |
370 |
PURPURA |
3 |
0.0004 |
371 |
NECK INJURY |
1 |
0.0004 |
372 |
HYPOAESTHESIA ORAL |
5 |
0.0004 |
373 |
THROAT IRRITATION |
14 |
0.0004 |
374 |
EXCORIATION |
1 |
0.0004 |
375 |
DIASTOLIC DYSFUNCTION |
1 |
0.0004 |
376 |
FEELING HOT |
20 |
0.0004 |
377 |
ERYTHEMA MULTIFORME |
3 |
0.0004 |
378 |
ABSCESS |
5 |
0.0004 |
379 |
INFLAMMATION |
15 |
0.0004 |
380 |
EXTRA DOSE ADMINISTERED |
9 |
0.0004 |
381 |
ONYCHOMADESIS |
1 |
0.0004 |
382 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0004 |
383 |
PREMATURE LABOUR |
2 |
0.0004 |
384 |
ENCEPHALITIS |
2 |
0.0004 |
385 |
BLOOD BLISTER |
1 |
0.0004 |
386 |
CREPITATIONS |
1 |
0.0004 |
387 |
POSTURE ABNORMAL |
1 |
0.0004 |
388 |
VENTRICULAR HYPOKINESIA |
1 |
0.0004 |
389 |
ATELECTASIS |
3 |
0.0004 |
390 |
PROTHROMBIN TIME PROLONGED |
2 |
0.0004 |
391 |
LOOSE TOOTH |
1 |
0.0004 |
392 |
END STAGE RENAL DISEASE |
6 |
0.0004 |
393 |
ACCIDENTAL OVERDOSE |
10 |
0.0004 |
394 |
CHEST DISCOMFORT |
29 |
0.0004 |
395 |
THROMBOCYTOSIS |
1 |
0.0004 |
396 |
CHRONIC SINUSITIS |
1 |
0.0004 |
397 |
STUPOR |
1 |
0.0004 |
398 |
GENERALISED ERYTHEMA |
2 |
0.0004 |
399 |
PETECHIAE |
3 |
0.0003 |
400 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
401 |
FEELING COLD |
8 |
0.0003 |
402 |
RASH MACULO-PAPULAR |
6 |
0.0003 |
403 |
ECCHYMOSIS |
2 |
0.0003 |
404 |
SWELLING FACE |
18 |
0.0003 |
405 |
PHARYNGEAL SWELLING |
2 |
0.0003 |
406 |
LIVER TRANSPLANT |
1 |
0.0003 |
407 |
REBOUND ACID HYPERSECRETION |
1 |
0.0003 |
408 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
409 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
410 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
411 |
MEDICATION ERROR |
15 |
0.0003 |
412 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
413 |
PAROSMIA |
2 |
0.0003 |
414 |
HYPERACUSIS |
1 |
0.0003 |
415 |
BREAST PAIN |
3 |
0.0003 |
416 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
417 |
INVESTIGATION |
1 |
0.0003 |
418 |
ANAL INCONTINENCE |
2 |
0.0003 |
419 |
THROMBOSIS IN DEVICE |
1 |
0.0003 |
420 |
FACIAL PARESIS |
1 |
0.0003 |
421 |
OEDEMA MOUTH |
1 |
0.0003 |
422 |
HYPOAESTHESIA |
39 |
0.0003 |
423 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0003 |
424 |
TONGUE DISORDER |
2 |
0.0003 |
425 |
MUSCLE HAEMORRHAGE |
1 |
0.0003 |
426 |
SWELLING |
23 |
0.0003 |
427 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0003 |
428 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
429 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
430 |
CYTOLYTIC HEPATITIS |
1 |
0.0003 |
431 |
ABSCESS LIMB |
1 |
0.0003 |
432 |
TRIGEMINAL NEURALGIA |
1 |
0.0003 |
433 |
SENSORY LOSS |
2 |
0.0003 |
434 |
SKIN PLAQUE |
2 |
0.0003 |
435 |
WOUND SECRETION |
1 |
0.0003 |
436 |
LETHARGY |
14 |
0.0003 |
437 |
VIITH NERVE PARALYSIS |
1 |
0.0003 |
438 |
INJECTION SITE HAEMATOMA |
4 |
0.0003 |
439 |
SCRATCH |
2 |
0.0003 |
440 |
PARAESTHESIA |
38 |
0.0003 |
441 |
EYELID OEDEMA |
3 |
0.0003 |
442 |
LIP OEDEMA |
1 |
0.0003 |
443 |
FACE OEDEMA |
4 |
0.0003 |
444 |
CONVULSION |
16 |
0.0003 |
445 |
RASH VESICULAR |
1 |
0.0003 |
446 |
LIMB DISCOMFORT |
7 |
0.0003 |
447 |
SCAR |
4 |
0.0003 |
448 |
BLOOD CREATINE INCREASED |
1 |
0.0003 |
449 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0003 |
450 |
APPLICATION SITE EXFOLIATION |
1 |
0.0003 |
451 |
INJECTION SITE DISCOMFORT |
2 |
0.0003 |
452 |
TEARFULNESS |
1 |
0.0003 |
453 |
DRUG EXPOSURE DURING PREGNANCY |
9 |
0.0003 |
454 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0003 |
455 |
PERIPHERAL COLDNESS |
3 |
0.0003 |
456 |
SARCOIDOSIS |
1 |
0.0003 |
457 |
GESTATIONAL DIABETES |
1 |
0.0003 |
458 |
BURNING SENSATION |
15 |
0.0003 |
459 |
SKIN TIGHTNESS |
1 |
0.0003 |
460 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
461 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
462 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
463 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
464 |
HYPERNATRAEMIA |
1 |
0.0002 |
465 |
CATATONIA |
1 |
0.0002 |
466 |
FLUSHING |
22 |
0.0002 |
467 |
EAR DISCOMFORT |
2 |
0.0002 |
468 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
469 |
TONSILLITIS |
1 |
0.0002 |
470 |
PAIN IN EXTREMITY |
60 |
0.0002 |
471 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
472 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
473 |
BURSITIS |
2 |
0.0002 |
474 |
BLOOD PRESSURE DECREASED |
13 |
0.0002 |
475 |
ACCIDENTAL EXPOSURE TO PRODUCT |
14 |
0.0002 |
476 |
CHILLS |
23 |
0.0002 |
477 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
478 |
SKIN DISCOLOURATION |
9 |
0.0002 |
479 |
COLECTOMY |
1 |
0.0002 |
480 |
EYE SWELLING |
7 |
0.0002 |
481 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
482 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
483 |
HYPOTONIA |
2 |
0.0002 |
484 |
DYSGEUSIA |
15 |
0.0002 |
485 |
SKIN INFECTION |
2 |
0.0002 |
486 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
487 |
SKIN IRRITATION |
9 |
0.0002 |
488 |
INCORRECT PRODUCT STORAGE |
3 |
0.0002 |
489 |
INCONTINENCE |
2 |
0.0002 |
490 |
DYSPHAGIA |
17 |
0.0002 |
491 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
492 |
OEDEMA PERIPHERAL |
24 |
0.0002 |
493 |
SKIN NECROSIS |
1 |
0.0002 |
494 |
PYREXIA |
63 |
0.0002 |
495 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
496 |
HYPERKERATOSIS |
1 |
0.0002 |
497 |
RASH |
73 |
0.0002 |
498 |
LOSS OF CONSCIOUSNESS |
23 |
0.0002 |
499 |
FEAR OF INJECTION |
1 |
0.0002 |
500 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
501 |
DYSPHONIA |
10 |
0.0002 |
502 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
503 |
NERVE INJURY |
2 |
0.0002 |
504 |
HYPERHIDROSIS |
23 |
0.0002 |
505 |
JOINT RANGE OF MOTION DECREASED |
2 |
0.0002 |
506 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
507 |
FOOD ALLERGY |
1 |
0.0002 |
508 |
PHOTOPHOBIA |
3 |
0.0002 |
509 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
510 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0002 |
511 |
ANGIOPATHY |
1 |
0.0002 |
512 |
ILEUS |
2 |
0.0002 |
513 |
LEUKOCYTOSIS |
3 |
0.0002 |
514 |
RESPIRATORY DISORDER |
5 |
0.0002 |
515 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
516 |
FEAR |
5 |
0.0002 |
517 |
OVERDOSE |
36 |
0.0002 |
518 |
APPETITE DISORDER |
1 |
0.0002 |
519 |
URINARY INCONTINENCE |
5 |
0.0002 |
520 |
HEART RATE DECREASED |
6 |
0.0002 |
521 |
MYOCLONUS |
2 |
0.0002 |
522 |
ANAPHYLACTIC SHOCK |
4 |
0.0002 |
523 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
524 |
PAPULE |
1 |
0.0002 |
525 |
HYPERVENTILATION |
1 |
0.0002 |
526 |
HEART RATE INCREASED |
16 |
0.0002 |
527 |
DYSPNOEA |
91 |
0.0002 |
528 |
PRODUCT LABEL ISSUE |
1 |
0.0002 |
529 |
DRUG DISPENSING ERROR |
3 |
0.0002 |
530 |
SCOLIOSIS |
1 |
0.0002 |
531 |
PHOTOPSIA |
1 |
0.0002 |
532 |
NODULE |
2 |
0.0002 |
533 |
PULMONARY CONGESTION |
2 |
0.0002 |
534 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
535 |
HEPATITIS ACUTE |
1 |
0.0002 |
536 |
PALPITATIONS |
18 |
0.0002 |
537 |
MENINGITIS |
1 |
0.0002 |
538 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0002 |
539 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0002 |
540 |
LYMPHOEDEMA |
1 |
0.0002 |
541 |
APHONIA |
2 |
0.0002 |
542 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
543 |
MUSCLE SPASTICITY |
2 |
0.0002 |
544 |
ONYCHOCLASIS |
1 |
0.0002 |
545 |
NEPHROTIC SYNDROME |
1 |
0.0002 |
546 |
INJECTION SITE BRUISING |
11 |
0.0002 |
547 |
ULCER HAEMORRHAGE |
1 |
0.0002 |
548 |
SKIN SWELLING |
1 |
0.0002 |
549 |
BRADYCARDIA |
8 |
0.0002 |
550 |
DYSKINESIA |
6 |
0.0002 |
551 |
STAPHYLOCOCCAL INFECTION |
5 |
0.0002 |
552 |
EYE MOVEMENT DISORDER |
1 |
0.0002 |
553 |
ABORTION SPONTANEOUS |
6 |
0.0002 |
554 |
OCULAR HYPERAEMIA |
6 |
0.0002 |
555 |
RESPIRATORY DISTRESS |
4 |
0.0002 |
556 |
GRIP STRENGTH DECREASED |
1 |
0.0002 |
557 |
MUSCULAR WEAKNESS |
16 |
0.0002 |
558 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
559 |
MAJOR DEPRESSION |
1 |
0.0002 |
560 |
DUODENAL ULCER |
1 |
0.0002 |
561 |
GASTROENTERITIS |
2 |
0.0002 |
562 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0002 |
563 |
DIZZINESS |
68 |
0.0002 |
564 |
BRONCHOSPASM |
2 |
0.0002 |
565 |
THERMAL BURN |
1 |
0.0002 |
566 |
ORAL DISORDER |
1 |
0.0002 |
567 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0002 |
568 |
HYDRONEPHROSIS |
1 |
0.0002 |
569 |
FORMICATION |
1 |
0.0002 |
570 |
HYPOKINESIA |
2 |
0.0002 |
571 |
IMMUNOSUPPRESSION |
1 |
0.0002 |
572 |
IMPAIRED WORK ABILITY |
3 |
0.0002 |
573 |
COORDINATION ABNORMAL |
2 |
0.0002 |
574 |
RESPIRATORY TRACT CONGESTION |
2 |
0.0002 |
575 |
ESCHERICHIA INFECTION |
1 |
0.0002 |
576 |
MELAENA |
3 |
0.0002 |
577 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0002 |
578 |
HEAD INJURY |
4 |
0.0002 |
579 |
TREMOR |
22 |
0.0002 |
580 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0002 |
581 |
PSEUDOMONAS INFECTION |
1 |
0.0002 |
582 |
MUSCLE TWITCHING |
3 |
0.0002 |
583 |
FACIAL PARALYSIS |
1 |
0.0002 |
584 |
PNEUMONIA BACTERIAL |
1 |
0.0002 |
585 |
MUSCULOSKELETAL STIFFNESS |
11 |
0.0002 |
586 |
ULCER |
2 |
0.0002 |
587 |
SYNOVITIS |
2 |
0.0002 |
588 |
PRODUCT PACKAGING QUANTITY ISSUE |
1 |
0.0002 |
589 |
TUMOUR LYSIS SYNDROME |
1 |
0.0002 |
590 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
3 |
0.0002 |
591 |
AORTIC ANEURYSM |
1 |
0.0002 |
592 |
CONJUNCTIVITIS |
2 |
0.0002 |
593 |
DEVICE RELATED INFECTION |
2 |
0.0002 |
594 |
MYOSITIS |
1 |
0.0001 |
595 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
596 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
597 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
598 |
APNOEA |
1 |
0.0001 |
599 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
1 |
0.0001 |
600 |
RENAL CYST |
1 |
0.0001 |
601 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
602 |
CHEST PAIN |
23 |
0.0001 |
603 |
DRUG HYPERSENSITIVITY |
24 |
0.0001 |
604 |
ATRIAL FLUTTER |
1 |
0.0001 |
605 |
BLOOD PRESSURE FLUCTUATION |
3 |
0.0001 |
606 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
607 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
608 |
EMBOLISM |
1 |
0.0001 |
609 |
DIZZINESS POSTURAL |
1 |
0.0001 |
610 |
ANGIOEDEMA |
5 |
0.0001 |
611 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
612 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
613 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
614 |
BRAIN NEOPLASM |
1 |
0.0001 |
615 |
MIDDLE INSOMNIA |
2 |
0.0001 |
616 |
WOUND INFECTION |
1 |
0.0001 |
617 |
FLUID OVERLOAD |
2 |
0.0001 |
618 |
PATHOGEN RESISTANCE |
1 |
0.0001 |
619 |
HEMIPARESIS |
2 |
0.0001 |
620 |
BLOOD PRESSURE INCREASED |
17 |
0.0001 |
621 |
OROPHARYNGEAL PAIN |
10 |
0.0001 |
622 |
PERIPHERAL SWELLING |
16 |
0.0001 |
623 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
624 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
625 |
EYE PRURITUS |
3 |
0.0001 |
626 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
627 |
RESTLESS LEGS SYNDROME |
2 |
0.0001 |
628 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
629 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
630 |
FLANK PAIN |
1 |
0.0001 |
631 |
OPTIC NEURITIS |
1 |
0.0001 |
632 |
LUNG INFECTION |
2 |
0.0001 |
633 |
EAR PAIN |
2 |
0.0001 |
634 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
635 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
636 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
637 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
638 |
LUNG INFILTRATION |
1 |
0.0001 |
639 |
COUGH |
27 |
0.0001 |
640 |
NEPHROPATHY |
1 |
0.0001 |
641 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
642 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
643 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
644 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
645 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
646 |
LARYNGITIS |
1 |
0.0001 |
647 |
ASPIRATION |
1 |
0.0001 |
648 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
649 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
650 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
651 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
652 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
653 |
SNEEZING |
2 |
0.0001 |
654 |
HEPATOMEGALY |
1 |
0.0001 |
655 |
MALNUTRITION |
1 |
0.0001 |
656 |
SKIN DISORDER |
3 |
0.0001 |
657 |
ASTHENIA |
35 |
0.0001 |
658 |
NAUSEA |
73 |
0.0001 |
659 |
DERMATITIS CONTACT |
1 |
0.0001 |
660 |
NASAL CONGESTION |
5 |
0.0001 |
661 |
SCAB |
1 |
0.0001 |
662 |
SECRETION DISCHARGE |
1 |
0.0001 |
663 |
POLYNEUROPATHY |
1 |
0.0001 |
664 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
4 |
0.0001 |
665 |
STATUS EPILEPTICUS |
1 |
0.0001 |
666 |
AMNESIA |
6 |
0.0001 |
667 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
668 |
GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0001 |
669 |
INJECTION SITE NODULE |
1 |
0.0001 |
670 |
TINNITUS |
4 |
0.0001 |
671 |
LACERATION |
1 |
0.0001 |
672 |
SCHIZOPHRENIA |
1 |
0.0001 |
673 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
674 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
675 |
EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
676 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
677 |
CONTUSION |
8 |
0.0001 |
678 |
GENERALISED OEDEMA |
1 |
0.0001 |
679 |
EYE IRRITATION |
4 |
0.0001 |
680 |
HEADACHE |
52 |
0.0001 |
681 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
682 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
15 |
0.0001 |
683 |
SEASONAL ALLERGY |
1 |
0.0001 |
684 |
EYE PAIN |
4 |
0.0001 |
685 |
PAIN |
50 |
0.0001 |
686 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
687 |
BALANCE DISORDER |
7 |
0.0001 |
688 |
GINGIVAL BLEEDING |
1 |
0.0001 |
689 |
DYSARTHRIA |
3 |
0.0001 |
690 |
TOOTH EXTRACTION |
1 |
0.0001 |
691 |
JOINT SWELLING |
9 |
0.0001 |
692 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
693 |
TACHYPNOEA |
1 |
0.0001 |
694 |
SEIZURE |
8 |
0.0001 |
695 |
HAEMATOCHEZIA |
4 |
0.0001 |
696 |
HAEMATEMESIS |
2 |
0.0001 |
697 |
BEDRIDDEN |
1 |
0.0001 |
698 |
SPEECH DISORDER |
4 |
0.0001 |
699 |
VOMITING |
34 |
0.0001 |
700 |
LACRIMATION INCREASED |
2 |
0.0001 |
701 |
ARTHRALGIA |
29 |
0.0001 |
702 |
HEPATITIS C |
1 |
0.0001 |
703 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
704 |
FEELING ABNORMAL |
18 |
0.0001 |
705 |
ORAL DISCOMFORT |
1 |
0.0001 |
706 |
DEEP VEIN THROMBOSIS |
5 |
0.0001 |
707 |
PULMONARY MASS |
1 |
0.0001 |
708 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
709 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
710 |
MYALGIA |
12 |
0.0001 |
711 |
HYPOTENSION |
14 |
0.0001 |
712 |
RENAL FAILURE |
10 |
0.0001 |
713 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
714 |
PRODUCT PREPARATION ERROR |
1 |
0.0001 |
715 |
MUSCULOSKELETAL PAIN |
4 |
0.0001 |
716 |
PARALYSIS |
1 |
0.0001 |
717 |
ECZEMA |
2 |
0.0001 |
718 |
DIALYSIS |
1 |
0.0001 |
719 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
720 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
721 |
VISION BLURRED |
9 |
0.0001 |
722 |
GAIT DISTURBANCE |
13 |
0.0001 |
723 |
ABASIA |
2 |
0.0001 |
724 |
THYROID DISORDER |
1 |
0.0001 |
725 |
PULMONARY OEDEMA |
3 |
0.0001 |
726 |
CANDIDA INFECTION |
1 |
0.0001 |
727 |
RHINORRHOEA |
4 |
0.0001 |
728 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
729 |
APHASIA |
2 |
0.0001 |
730 |
VIRAL INFECTION |
2 |
0.0001 |
731 |
LUNG DISORDER |
3 |
0.0001 |
732 |
ANOREXIA |
1 |
0.0001 |
733 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
734 |
TENDONITIS |
1 |
0.0001 |
735 |
ERUCTATION |
1 |
0.0001 |
736 |
ASTHMA |
6 |
0.0001 |
737 |
BACK DISORDER |
1 |
0.0001 |
738 |
FUNGAL INFECTION |
2 |
0.0001 |
739 |
MOVEMENT DISORDER |
2 |
0.0001 |
740 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
741 |
DELIRIUM |
2 |
0.0001 |
742 |
DRUG TOXICITY |
1 |
0.0001 |
743 |
BLOOD GLUCOSE DECREASED |
3 |
0.0001 |
744 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
745 |
DEHYDRATION |
8 |
0.0001 |
746 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
747 |
AGRANULOCYTOSIS |
1 |
0.0001 |
748 |
RENAL INJURY |
2 |
0.0001 |
749 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
750 |
ANXIETY |
17 |
0.0001 |
751 |
AMENORRHOEA |
1 |
0.0001 |
752 |
MALAISE |
26 |
0.0001 |
753 |
COAGULOPATHY |
1 |
0.0001 |
754 |
HAEMOGLOBIN DECREASED |
6 |
0.0001 |
755 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
756 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
757 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
758 |
HAEMATURIA |
2 |
0.0001 |
759 |
BLOOD UREA INCREASED |
1 |
0.0001 |
760 |
DISCOMFORT |
3 |
0.0001 |
761 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0001 |
762 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
763 |
ISCHAEMIC STROKE |
1 |
0.0001 |
764 |
ADVERSE EVENT |
5 |
0.0001 |
765 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
766 |
HERNIA |
1 |
0.0001 |
767 |
DERMATITIS |
1 |
0.0001 |
768 |
NECK PAIN |
3 |
0.0001 |
769 |
GALLBLADDER DISORDER |
1 |
0.0001 |
770 |
DYSURIA |
2 |
0.0001 |
771 |
OSTEOMYELITIS |
1 |
0.0001 |
772 |
ANAEMIA |
10 |
0.0001 |
773 |
INSOMNIA |
14 |
0.0001 |
774 |
CRYING |
2 |
0.0001 |
775 |
SINUS DISORDER |
1 |
0.0001 |
776 |
BONE PAIN |
3 |
0.0001 |
777 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
778 |
INFUSION RELATED REACTION |
3 |
0.0001 |
779 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
780 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0001 |
781 |
POOR QUALITY SLEEP |
1 |
0.0001 |
782 |
FATIGUE |
37 |
0.0001 |
783 |
GLOSSODYNIA |
1 |
0.0001 |
784 |
MUSCLE SPASMS |
9 |
0.0001 |
785 |
VERTIGO |
3 |
0.0001 |
786 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
787 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
788 |
BACK PAIN |
11 |
0.0001 |
789 |
PULMONARY HYPERTENSION |
1 |
0.0001 |
790 |
PRODUCTIVE COUGH |
2 |
0.0001 |
791 |
EATING DISORDER |
1 |
0.0001 |
792 |
THROMBOCYTOPENIA |
5 |
0.0001 |
793 |
SHOCK |
1 |
0.0001 |
794 |
TOOTH LOSS |
1 |
0.0001 |
795 |
PREGNANCY |
1 |
0.0001 |
796 |
SEPSIS |
5 |
0.0001 |
797 |
BLOOD CREATININE INCREASED |
3 |
0.0001 |
798 |
HYPOKALAEMIA |
2 |
0.0001 |
799 |
NEEDLE ISSUE |
1 |
0.0001 |
800 |
NEURALGIA |
1 |
0.0001 |
801 |
URINARY TRACT INFECTION |
7 |
0.0001 |
802 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
803 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0001 |
804 |
UNDERDOSE |
3 |
0.0001 |
805 |
RESPIRATORY TRACT INFECTION |
1 |
0.0001 |
806 |
ENCEPHALOPATHY |
1 |
0.0001 |
807 |
LOCALISED INFECTION |
1 |
0.0001 |
808 |
APPLICATION SITE PRURITUS |
1 |
0.0001 |
809 |
SKIN BURNING SENSATION |
3 |
0.0001 |
810 |
HYPOPHAGIA |
1 |
0.0001 |
811 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
812 |
RESPIRATORY FAILURE |
3 |
0.0000 |
813 |
WOUND |
1 |
0.0000 |
814 |
HYPOGLYCAEMIA |
2 |
0.0000 |
815 |
CEREBRAL INFARCTION |
1 |
0.0000 |
816 |
SINUSITIS |
4 |
0.0000 |
817 |
DEAFNESS |
1 |
0.0000 |
818 |
INJURY |
3 |
0.0000 |
819 |
BRONCHITIS |
3 |
0.0000 |
820 |
DEMENTIA |
1 |
0.0000 |
821 |
SKIN EXFOLIATION |
3 |
0.0000 |
822 |
LIMB INJURY |
1 |
0.0000 |
823 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
824 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
825 |
ARTHRITIS |
3 |
0.0000 |
826 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
827 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
828 |
PROCEDURAL PAIN |
1 |
0.0000 |
829 |
JOINT STIFFNESS |
1 |
0.0000 |
830 |
UNEVALUABLE EVENT |
3 |
0.0000 |
831 |
GASTRITIS |
1 |
0.0000 |
832 |
ACNE |
3 |
0.0000 |
833 |
PANCYTOPENIA |
2 |
0.0000 |
834 |
INFECTION |
5 |
0.0000 |
835 |
CONFUSIONAL STATE |
6 |
0.0000 |
836 |
HAEMATOMA |
1 |
0.0000 |
837 |
ARTHROPATHY |
2 |
0.0000 |
838 |
PAIN OF SKIN |
1 |
0.0000 |
839 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
840 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
841 |
HAEMOPTYSIS |
1 |
0.0000 |
842 |
ABDOMINAL PAIN |
8 |
0.0000 |
843 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
844 |
PRODUCT USE ISSUE |
6 |
0.0000 |
845 |
TACHYCARDIA |
3 |
0.0000 |
846 |
PAIN IN JAW |
1 |
0.0000 |
847 |
DRY SKIN |
4 |
0.0000 |
848 |
ANHEDONIA |
1 |
0.0000 |
849 |
ABNORMAL DREAMS |
1 |
0.0000 |
850 |
ILLNESS |
2 |
0.0000 |
851 |
MIGRAINE |
3 |
0.0000 |
852 |
CARDIAC FAILURE CONGESTIVE |
3 |
0.0000 |
853 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
854 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
855 |
NIGHT SWEATS |
1 |
0.0000 |
856 |
RESPIRATORY ARREST |
1 |
0.0000 |
857 |
DIARRHOEA |
20 |
0.0000 |
858 |
PLEURAL EFFUSION |
2 |
0.0000 |
859 |
HEPATIC FAILURE |
1 |
0.0000 |
860 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
861 |
IMPAIRED HEALING |
1 |
0.0000 |
862 |
IRRITABILITY |
2 |
0.0000 |
863 |
EYE DISORDER |
1 |
0.0000 |
864 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
865 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
866 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
867 |
CYSTITIS |
1 |
0.0000 |
868 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
869 |
CHOLELITHIASIS |
1 |
0.0000 |
870 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
871 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
872 |
HOSPITALISATION |
4 |
0.0000 |
873 |
HYPOXIA |
1 |
0.0000 |
874 |
HYPERKALAEMIA |
1 |
0.0000 |
875 |
INJECTION SITE MASS |
1 |
0.0000 |
876 |
MOBILITY DECREASED |
2 |
0.0000 |
877 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
878 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
879 |
NASOPHARYNGITIS |
5 |
0.0000 |
880 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
881 |
HALLUCINATION |
2 |
0.0000 |
882 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
883 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
884 |
FALL |
9 |
0.0000 |
885 |
DECREASED APPETITE |
6 |
0.0000 |
886 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
887 |
RESTLESSNESS |
1 |
0.0000 |
888 |
EPISTAXIS |
2 |
0.0000 |
889 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
890 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
891 |
AGITATION |
2 |
0.0000 |
892 |
CONDITION AGGRAVATED |
7 |
0.0000 |
893 |
DRY EYE |
1 |
0.0000 |
894 |
DRY MOUTH |
2 |
0.0000 |
895 |
BLINDNESS |
1 |
0.0000 |
896 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
897 |
HYPOACUSIS |
1 |
0.0000 |
898 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
899 |
RENAL IMPAIRMENT |
2 |
0.0000 |
900 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
901 |
SEPTIC SHOCK |
1 |
0.0000 |
902 |
OSTEOARTHRITIS |
1 |
0.0000 |
903 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
904 |
HYPERTENSION |
5 |
0.0000 |
905 |
DISORIENTATION |
1 |
0.0000 |
906 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
907 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
908 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
909 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
910 |
COGNITIVE DISORDER |
1 |
0.0000 |
911 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
912 |
DEPRESSION |
5 |
0.0000 |
913 |
DYSPEPSIA |
2 |
0.0000 |
914 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
915 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
916 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
917 |
ARRHYTHMIA |
1 |
0.0000 |
918 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
919 |
INFLUENZA |
2 |
0.0000 |
920 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
921 |
PNEUMONIA |
6 |
0.0000 |
922 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
923 |
OEDEMA |
1 |
0.0000 |
924 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
925 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
926 |
FLATULENCE |
1 |
0.0000 |
927 |
DEATH |
15 |
0.0000 |
928 |
NERVOUSNESS |
1 |
0.0000 |
929 |
STOMATITIS |
1 |
0.0000 |
930 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
931 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
932 |
NEUTROPENIA |
2 |
0.0000 |
933 |
SLEEP DISORDER |
1 |
0.0000 |
934 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
935 |
HOT FLUSH |
1 |
0.0000 |
936 |
WEIGHT DECREASED |
4 |
0.0000 |
937 |
STRESS |
1 |
0.0000 |
938 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
939 |
DEVICE ISSUE |
1 |
0.0000 |
940 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
941 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
942 |
CARDIAC FAILURE |
1 |
0.0000 |
943 |
THROMBOSIS |
1 |
0.0000 |
944 |
CARDIAC ARREST |
1 |
0.0000 |
945 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
946 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
947 |
SUICIDAL IDEATION |
1 |
0.0000 |
948 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
949 |
CARDIAC DISORDER |
1 |
0.0000 |
950 |
PULMONARY EMBOLISM |
1 |
0.0000 |
951 |
BREAST CANCER |
1 |
0.0000 |
952 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
953 |
DRUG INEFFECTIVE |
10 |
0.0000 |
954 |
PSORIASIS |
1 |
0.0000 |
955 |
OFF LABEL USE |
5 |
0.0000 |
956 |
COVID-19 |
1 |
0.0000 |
957 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
958 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
959 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
960 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
961 |
ALOPECIA |
1 |
0.0000 |
962 |
SOMNOLENCE |
1 |
0.0000 |
963 |
DRUG DOSE OMISSION |
1 |
0.0000 |
964 |
CONSTIPATION |
1 |
0.0000 |